Fruitflow, a New Product from DSM that Helps Maintain a Healthy Blood Flow, Wins the 2011 Nutraward

Parsippany, NJ (March 31, 2011) – Fruitflow®, a natural, water-soluble patented tomato concentrate, took home the Nutraward for Best New Ingredient at the Nutracon conference in Anaheim on March 10th 2011. Judged by a scientific panel and voters on the Nutracon website, Fruitflow was chosen best amongst 12 new ingredients that competed for the top spot.

“Fruitflow® is truly unique” commented Reto Rieder, Senior Marketing Manager DSM Nutritional Products, “by helping to keep the platelets smooth, Fruitflow® has been shown to maintain healthy platelet function in 2 published human studies. Its impressive clinical data and safety profile resulted in EFSA awarding Fruitflow one of the first approved Article 13.5 Health Food claims in Europe.”

At the same time, the first commercial products containing Fruitflow® in the US were launched by Shrewsbury, NJ based Relaxzen, two shot type products aimed at business travelers.

Late 2010 DSM had signed a partnership agreement with UK based Provexis Nutrition, the company that developed Fruitflow and supported multiple human studies with Fruitflow.

“We feel Fruitflow® has a bright future as it is natural, has an excellent safety profile, compelling human published data and an EFSA Health claim in Europe” says, Rieder

 

DSM – Bright Science. Brighter Living.™

Royal DSM N.V. is a global science-based company active in health, nutrition and materials.

By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM’s 22,000 employees deliver annual net sales of around $12 billion US. The company is listed on NYSE Euronext. More information can be found at www.dsm.com.